Authors: IBERER F GRASSER B SCHREIER G SCHAFFELLNER S PRENNER G ALLMAYER T WASLER A PETUTSCHNIGG B MULLER H KASTNER P SCHALDACH M HUTTEN H TSCHELIESSNIGG KH

Citation: F. Iberer et al., INTRODUCING A NEW CLINICAL METHOD FOR NONINVASIVE REJECTION MONITORING AFTER HEART-TRANSPLANTATION TO CLINICAL-PRACTICE - ANALYSIS OF PACEDINTRAMYOCARDIAL ELECTROGRAMS, Transplantation proceedings, 30(3), 1998, pp. 895-899

Authors: IBERER F GRASSER B SCHREIER G PRENNER G SCHAFFELLNER S ALLMAYER T WASLER A PETUTSCHNIGG B MULLER H HUTTEN H SCHALDACH M TSCHELIESSNIGG KH

Citation: F. Iberer et al., NONINVASIVE REJECTION MONITORING AFTER HEART-TRANSPLANT, Transplantation proceedings, 29(7), 1997, pp. 3126-3126

Authors: IBERER F TSCHELIESSNIGG K HALWACHS G REHAK P WASLER A PETUTSCHNIGG B SCHREIER G MULLER H ALLMAYER T FREIGASSNER M PRENNER G HIPMAIR G GRASSER B

Citation: F. Iberer et al., DEFINITIONS OF CYTOMEGALOVIRUS DISEASE AFTER HEART-TRANSPLANTATION - ANTIGENEMIA AS A MARKER FOR ANTIVIRAL THERAPY, Transplant international, 9(3), 1996, pp. 236-242

Authors: EGGER G ALLMAYER T IBERER F TSCHELIESSNIGG KH AUER T WASLER A PETUTSCHNIGG B

Citation: G. Egger et al., IMPAIRED POLYMORPHONUCLEAR LEUKOCYTE MIGRATION AS A POSSIBLE MONITOR FOR THE RISK OF SEPTICEMIA IN IMMUNOSUPPRESSED TRANSPLANT PATIENTS, Medical science research, 24(1), 1996, pp. 17-19

Authors: IBERER F TSCHELIESSNIGG K HALWACHS G AUER T WASLER A PETUTSCHNIGG B SCHREIER G MULLER H ALLMAYER T PRENNER G HIPPMAIR G GRASSER B FREIGASSNER M

Citation: F. Iberer et al., CYTOMEGALOVIRUS AFTER HEART-TRANSPLANTATION - DEFINITIONS FOR THE GUIDANCE OF ANTIVIRAL THERAPY, Scandinavian journal of infectious diseases, 1995, pp. 100-103

Authors: IBERER F VUJICIC R RODL S WASLER A SABIN K KOSHSORUR A ALLMAYER T AUER T PETUTSCHNIGG B TSCHELIESSNIGG KH

Citation: F. Iberer et al., EFFECTS OF PROSTAGLANDIN E(1) THERAPY ON CYCLOSPORINE-A AND CREATININE LEVELS AFTER ORTHOTOPIC HEART-TRANSPLANTATION, Transplantation proceedings, 26(6), 1994, pp. 3246-3248